News

Federal immigration officials announced final rules to modernize the H-2A and H-2B temporary worker programs last week in an effort to enhance flexibility, strengthen worker protections, and improve program efficiency beginning January 17, 2025.

Recently, the Ohio Department of Commerce issued an alert that nonbank entities receiving compensation for arranging or brokering bank loans of $5,000 or less must obtain a license under the Small Loan Act (SLA).

On December 10, 2024, the federal government unsealed an indictment in federal court in Indiana, charging Chinese national Guan Tianfeng (Guan) for his role in allegedly breaking into thousands of Sophos Ltd. (Sophos) firewall devices globally in 2020.

The recent homicide of UnitedHealthcare CEO Brian Thompson has put a spotlight on executive security and has prompted many companies to reassess how they are protecting their top executives.

On December 16, the CFPB released its Supervisory Highlights: Special Edition Student Lending, Issue 36 (Winter 2024) which examined federal and private student loans and identified alleged violations in student loan refinancing, private lending and servicing, debt collection, and federal loan se

The December 18, 2024, issue of ECHA Weekly includes an item announcing the release of the European Chemicals Agency’s (ECHA) draft Community Rolling Action Plan (CoRAP) update for years 2025-27.

US Congress on December 20, 2024 passed a last-minute temporary government funding bill that keeps the government open for three months. As part of this package, a number of existing telehealth flexibilities were also extended to March 31, 2025.

On December 17, NYDFS introduced a new regulation, NEW 3 NYCRR 120, Compliance with Banking Law Section 28-bb, which would require nonbank mortgage bankers in New York State to collect and report data related to home loans to ensure that mortgage bankers meet the credit needs of their communities

The U.S. Department of Agriculture (USDA) Animal and Plant Health Inspection Service (APHIS) announced an abrupt reversion to its pre-2020 approach to biotechnology regulation on December 19, in the wake of a December 2 ruling by the U.S.

Pages